These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2988692)

  • 21. Anti-HTLV-III positive laboratory reagents.
    Jones P; Hamilton PJ; Oxley A; Codd A; Tedder R
    Lancet; 1985 Jun; 1(8443):1458-9. PubMed ID: 2861405
    [No Abstract]   [Full Text] [Related]  

  • 22. HTLV-III antibody in sequential plasma samples: from haemophiliacs 1974-84.
    Madhok R; Melbye M; Lowe GD; Forbes CD; Froebel KS; Bodner AJ; Biggar RJ
    Lancet; 1985 Mar; 1(8427):524-5. PubMed ID: 2857891
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-LAV and concentrate consumption in Italian hemophiliacs.
    Mannucci PM; Ammassari M; Gringeri A; Geroldi D; Zanetti AR
    Thromb Haemost; 1985 Aug; 54(2):556. PubMed ID: 3001966
    [No Abstract]   [Full Text] [Related]  

  • 24. Absence of HTLV-III antibody in blood donors and recipients in India.
    Simoes E; Kirubakaran M; John TJ; Tzan N; Madden D; Sever JL
    Lancet; 1985 Nov; 2(8466):1248. PubMed ID: 2866325
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation into the actual conditions of the prevention of HTLV-I infections].
    Nishimura Y; Shimamura N; Matsuo Y; Shinda I; Yamaguchi K
    Rinsho Ketsueki; 1987 Oct; 28(10):1984-6. PubMed ID: 2898547
    [No Abstract]   [Full Text] [Related]  

  • 27. Transfusion associated AIDS.
    Menitove JE
    J Clin Apher; 1985; 2(4):423-6. PubMed ID: 2999091
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibodies to AIDS and heated factor VIII.
    Mannucci PM; Gringeri A; Ammassari M
    Lancet; 1985 Jun; 1(8444):1505-6. PubMed ID: 2861430
    [No Abstract]   [Full Text] [Related]  

  • 29. [LAV/HTLV-III antibodies in blood and blood products].
    Gürtler L; Eberle J; Deinhardt F
    Dtsch Med Wochenschr; 1985 Oct; 110(43):1639-40. PubMed ID: 2994977
    [No Abstract]   [Full Text] [Related]  

  • 30. One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates.
    Rodeghiero F; Castaman GC; Chisesi T; De Rossi A; Dalla Gassa O; Del Mistro A; Dini E; Castronovo S; Pornaro E; Chieco-Bianchi L
    Thromb Haemost; 1985 Oct; 54(3):665-8. PubMed ID: 3003954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIDS and haemophilia: morbidity and morality in a well defined population.
    Jones P; Hamilton PJ; Bird G; Fearns M; Oxley A; Tedder R; Cheingsong-Popov R; Codd A
    Br Med J (Clin Res Ed); 1985 Sep; 291(6497):695-9. PubMed ID: 2994801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and early natural history of HTLV-III antibodies in persons with hemophilia.
    Eyster ME; Goedert JJ; Sarngadharan MG; Weiss SH; Gallo RC; Blattner WA
    JAMA; 1985 Apr; 253(15):2219-23. PubMed ID: 2983132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
    Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
    Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs.
    Melbye M; Ingerslev J; Biggar RJ; Alexander S; Sarin PS; Goedert JJ; Zachariae E; Ebbesen P; Stenbjerg S
    N Engl J Med; 1985 Mar; 312(13):857. PubMed ID: 2983213
    [No Abstract]   [Full Text] [Related]  

  • 35. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
    De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
    Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state].
    Aymard JP; Janot C; Chermann JC; Briquel ME; Perrier P; Alexandre P; Streiff F
    Rev Fr Transfus Immunohematol; 1985 Jun; 28(3):261-5. PubMed ID: 2994201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [AIDS--a further development].
    Aoki T; Taguchi Y; Kaneko Y
    Gan To Kagaku Ryoho; 1986 May; 13(5):1791-7. PubMed ID: 3010882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
    Evensen SA; Frøland SS; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
    [No Abstract]   [Full Text] [Related]  

  • 39. Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention.
    Okochi K; Sato H
    AIDS Res; 1986 Dec; 2 Suppl 1():S157-61. PubMed ID: 2881554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemophiliacs and acquired immune deficiency syndrome.
    Lin TA; Zhao JQ; Rabin B
    Chin Med J (Engl); 1985 Jun; 98(6):444-6. PubMed ID: 2996841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.